Number of the records: 1
The Adapted POM Analysis of Avenanthramides In Silico
Title The Adapted POM Analysis of Avenanthramides In Silico Author Maliar T. Co-authors Maliarová Mária Purdešová Andrea Jankech Timotej SAVNEIMU - Neuroimunologický ústav SAV Gerhardtová Ivana SAVNEIMU - Neuroimunologický ústav SAV Beňovič Patrik Viskupičová Jana 1983- SAVEXFATO - Ústav experimentálnej farmakológie a toxikológie SAV SCOPUS Co-authors Dvořáček Václav Jágr Michal Source document Pharmaceuticals. Vol. 16, no. 5 (2023), art. no. 717 Language eng - English Country CH - Switzerland Note SRDA-20-0413, NAZV QK1810102 Document kind rozpis článkov z periodík (rbx) Citations ALMINDEREJ, F. - GHANNAY, S. - ELSAMANI, M.O. - ALHAWDAY, F. - ALBADRI, A.E.A.E. - ELBEHAIRI, S.E.I. - ALFAIFI, M.Y. - KADRI, A. - AOUADI, K. In Vitro and In Silico Evaluation of Antiproliferative Activity of New Isoxazolidine Derivatives Targeting EGFR: Design, Synthesis, Cell Cycle Analysis, and Apoptotic Inducers. In PHARMACEUTICALS. JUL 2023, vol. 16, no. 7. Dostupné na: https://doi.org/10.3390/ph16071025. Category ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted) Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2023 Registered in WOS Registered in SCOPUS Registered in CCC DOI 10.3390/ph16050717 article
File name Access Size Downloaded Type License The Adapted POM Analysis of Avenanthramides In Silico.pdf available 1.5 MB 6 Publisher's version rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2023 2022 4.6 Q2 0.799 Q1
Number of the records: 1